Sage Journals: Discover world-class research

Open access

Research article

First published 2024

Extrafine single inhaler triple therapy effectiveness in COPD patients previously treated with multiple-inhaler triple therapy: the TRIWIN study

Paschalis Steiropoulos, Niki Georgatou, George Krommidas [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2018

Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate,umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects

Mario Malerba, Matteo Nardin, Giuseppe Santini [...]

Therapeutic Advances in Respiratory Disease

Retricted access

Research article

First published 2023-03

Therapeutic Response to Single-Inhaler Triple Therapies in Moderate-to-Severe COPD

Kengo Ohtsuka, Naoko Harada, Atsuo Horiuchi [...]

Respiratory Care

Open access

Review article

First published 2025

Extrafine formulation of beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurized metered-dose inhaler in the treatment of asthma: a review

Erminia Ridolo, Manlio Milanese, Alessandro Barone [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2023

Characteristics of initiators of budesonide/glycopyrrolate/formoterol for treatment of chronic obstructive pulmonary disease (COPD) in the United States: the AURA study

Edward C. Portillo, Michael Pollack, Inyoung Lee [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2024

Baseline patient demographics for TETRIS: a prospective,noninterventional study to characterize the use of triple therapy for COPD in Germany

Claus F. Vogelmeier, Kai-Michael Beeh, Peter Kardos [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2019

Triple therapy for COPD: a crude analysis from a systematic review of the evidence

Jose Luis Lopez-Campos, Laura Carrasco-Hernandez, Esther Quintana-Gallego [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2022

Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution

Fulvio Braido, Angelo G. Corsico, Davide Paleari [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2023

Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease

Corrado Pelaia, Giada Procopio, Fioramante Lello Rotundo [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2020

Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT

José M. Marín, Luis Mateos, Juan Roldán [...]

Therapeutic Advances in Respiratory Disease

Search results